CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices

The complaint is the latest move in a bitter legal fight between the U.S.’s three largest so-called pharmacy benefit managers, or PBMs, and the FTC.

  • Related Posts

    Burberry shares are down 40%. One hedge fund manager says the stock offers ‘good value’ right now

    Investors have welcomed Burberry’s new turnaround plan but shares remain down around 40% year-to-date.

    Three global stocks stocks to own in 2025, according to Barclays

    Barclays named “overweight-rated stocks in which our analysts have high conviction in 2025 and see value in owning on an individual basis.”

    Leave a Reply

    Your email address will not be published. Required fields are marked *